ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
68,040.78
0.47%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Artelo Biosciences Inc (ARTLW)

  7. Artelo Biosciences Inc (ARTLW) News

ARTLW

Artelo Biosciences (ARTLW)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTLW
DateTimeSourceHeadlineSymbolCompany
05/13/20249:17AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLWArtelo Biosciences Inc
03/04/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLWArtelo Biosciences Inc
03/01/20246:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLWArtelo Biosciences Inc
05/19/20205:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARTLWArtelo Biosciences Inc
05/18/20205:10PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARTLWArtelo Biosciences Inc
05/08/20204:32PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARTLWArtelo Biosciences Inc
04/15/20206:25AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARTLWArtelo Biosciences Inc
04/15/20206:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARTLWArtelo Biosciences Inc
04/14/20206:03AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARTLWArtelo Biosciences Inc
04/13/20204:28PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARTLWArtelo Biosciences Inc
04/13/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARTLWArtelo Biosciences Inc
04/07/20206:05AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARTLWArtelo Biosciences Inc
03/11/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARTLWArtelo Biosciences Inc
02/14/20204:40PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARTLWArtelo Biosciences Inc
02/14/20204:39PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARTLWArtelo Biosciences Inc
02/14/20204:39PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARTLWArtelo Biosciences Inc
11/18/20198:30AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewe...NASDAQ:ARTLWArtelo Biosciences Inc
11/14/20199:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the Annual Investival Showcase in LondonNASDAQ:ARTLWArtelo Biosciences Inc
10/29/20198:30AMGlobeNewswire Inc.Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART2...NASDAQ:ARTLWArtelo Biosciences Inc
10/22/20199:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth ConferenceNASDAQ:ARTLWArtelo Biosciences Inc
09/18/20198:00AMGlobeNewswire Inc.Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature MedicineNASDAQ:ARTLWArtelo Biosciences Inc
07/15/20194:01PMGlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ARTLWArtelo Biosciences Inc
06/25/20191:00PMGlobeNewswire Inc.Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Optio...NASDAQ:ARTLWArtelo Biosciences Inc
06/21/20191:50PMGlobeNewswire Inc.Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to NasdaqNASDAQ:ARTLWArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTLW

Your Recent History

USOTC
ENZC
Enzolytics (PK)
NASDAQ
NVDA
NVIDIA
USOTC
RNVA
Rennova Health (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
FNMA
Fannie Mae (QB)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
LWLG
Lightwave Logic
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IFUS
Impact Fusion (PK)
NYSE
AMC
AMC Entertainment
USOTC
CIVX
CTR Investments and Cons... (CE)
NASDAQ
NB
NioCorp Developments
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved